PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
+9.01%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.7B
AUM Growth
+$129M
(+5%)
Cap. Flow
-$25.7M
Cap. Flow
% of AUM
-0.95%
Top 10 Holdings %
Top 10 Hldgs %
38.9%
Holding
1,194
New
46
Increased
298
Reduced
730
Closed
120
Top Buys
| 1 |
NVIDIA
NVDA
|
+$45.9M |
| 2 |
Broadcom
AVGO
|
+$4.33M |
| 3 |
Booking.com
BKNG
|
+$3.04M |
| 4 |
Sarepta Therapeutics
SRPT
|
+$2.71M |
| 5 |
NextEra Energy, Inc.
NEE
|
+$2.61M |
Top Sells
| 1 |
Apple
AAPL
|
+$25.3M |
| 2 |
Amazon
AMZN
|
+$6.38M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$3.01M |
| 4 |
ConocoPhillips
COP
|
+$2.87M |
| 5 |
Novavax
NVAX
|
+$2.63M |
Sector Composition
| 1 | Technology | 47.26% |
| 2 | Healthcare | 11.3% |
| 3 | Consumer Discretionary | 9.84% |
| 4 | Communication Services | 9.16% |
| 5 | Financials | 4.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Simmons First National
SFNC
$2.96B
| $183K | 0.01% |
+10,413
| New | +$183K |
|
1002
Vipshop
VIPS
$8.72B
| $183K | 0.01% |
14,037
-12,902
| -48% | -$168K |
|
1003
Allogene Therapeutics
ALLO
$253M
| $177K | 0.01% |
76,160
-44,899
| -37% | -$105K |
|
1004
Apple Hospitality REIT
APLE
$2.99B
| $174K | 0.01% |
11,986
-323
| -3% | -$4.7K |
|
1005
Anavex Life Sciences
AVXL
$881M
| $174K | 0.01% |
41,280
-61,758
| -60% | -$261K |
|
1006
Liquidia Corp
LQDA
$2.39B
| $173K | 0.01% |
14,434
+3,466
| +32% | +$41.6K |
|
1007
Wipro
WIT
$29B
| $170K | 0.01% |
55,672
+2,282
| +4% | +$6.96K |
|
|
ALTM
1008
DELISTED
Arcadium Lithium plc
ALTM
| $169K | 0.01% |
50,286
-8,641
| -15% | -$29K |
|
1009
Heron Therapeutics
HRTX
$199M
| $168K | 0.01% |
+48,073
| New | +$168K |
|
|
PARA
1010
DELISTED
Paramount Global Class B
PARA
| $167K | 0.01% |
16,083
+2,783
| +21% | +$28.9K |
|
1011
Cassava Sciences
SAVA
$105M
| $166K | 0.01% |
13,440
+591
| +5% | +$7.3K |
|
1012
Sabra Healthcare REIT
SBRA
$4.58B
| $163K | 0.01% |
10,612
-1,139
| -10% | -$17.5K |
|
1013
Macerich
MAC
$4.57B
| $160K | 0.01% |
10,379
-1,285
| -11% | -$19.8K |
|
1014
BGC Group
BGC
$4.76B
| $160K | 0.01% |
19,245
-1,808
| -9% | -$15K |
|
1015
C4 Therapeutics
CCCC
$191M
| $158K | 0.01% |
34,149
-92,101
| -73% | -$426K |
|
1016
IAMGOLD
IAG
$5.76B
| $155K | 0.01% |
41,283
+1,656
| +4% | +$6.21K |
|
1017
Oric Pharmaceuticals
ORIC
$1.06B
| $155K | 0.01% |
21,861
+4,175
| +24% | +$29.5K |
|
1018
Fate Therapeutics
FATE
$113M
| $153K | 0.01% |
46,528
-65,823
| -59% | -$216K |
|
1019
MindMed
MNMD
$743M
| $150K | 0.01% |
+20,846
| New | +$150K |
|
1020
Eastern Bankshares
EBC
$3.4B
| $150K | 0.01% |
+10,694
| New | +$150K |
|
1021
Goodyear
GT
$2.45B
| $148K | 0.01% |
13,058
-1,303
| -9% | -$14.8K |
|
1022
Cabaletta Bio
CABA
$150M
| $144K | 0.01% |
19,250
-35,177
| -65% | -$263K |
|
1023
Amneal Pharmaceuticals
AMRX
$3.11B
| $143K | 0.01% |
22,522
+1,680
| +8% | +$10.7K |
|
1024
Equinox Gold
EQX
$7.78B
| $141K | 0.01% |
26,869
+1,788
| +7% | +$9.35K |
|
1025
ARS Pharmaceuticals
SPRY
$1.02B
| $137K | 0.01% |
16,129
-1,303
| -7% | -$11.1K |
|